Results 211 to 220 of about 304,634 (351)

Assessment of the Role of Neutrophil-Lymphocyte Ratio as a Prognostic Biomarker in Breast Cancer Patients: A Cross-sectional Study. [PDF]

Cancer Diagn Progn
Takada K, Kashiwagi S, Nishikawa M, Watanabe C, Tauchi Y, Ogisawa K, Shibutani M, Kinoshita H, Morisaki T.   +8 more
europepmc   +1 more source

Personal experience with orthotopic liver transplantation. [PDF]

, 1972
Corman, J, Groth, CG, Gustafsson, A, Halgrimson, CG, Penn, I, Putnam, CW, Schroter, G, Starzl, TE   +7 more
core  

Is Micronucleus Assay a Suitable Biomarker for Evaluating the Cancer Risk in Professionals Exposed to Antineoplastic Drugs? A Systematic Review

Journal of Applied Toxicology, EarlyView.
ABSTRACT The widespread use of antineoplastic drugs in cancer treatment has led to significant concerns regarding the potential health risks posed to healthcare professionals involved in the preparation, administration, and handling of these chemical compounds, including genotoxicity.
Thiago Guedes Pinto, Lorrany da Silva Avanci, Gabriel Carvalhal de Aguiar, Daniel Vitor de Souza, Patricia Ramos Cury, Ana Claudia Muniz Renno, Daniel Araki Ribeiro   +6 more
wiley   +1 more source

Bruton tyrosine kinase inhibitors in combination with chemoimmunotherapy is an effective treatment for patients with Richter's syndrome. [PDF]

Leuk Res Rep
Meier T, Huynh G, Ayala E, Tun HW, Iqbal M.   +4 more
europepmc   +1 more source

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia [PDF]

, 2011
Nobuko Hijiya, Blythe Thomson, Michael S. Isakoff, Lewis B. Silverman, Peter G. Steinherz, Michael J. Borowitz, Richard Kadota, Todd M. Cooper, Violet Shen, Gary V. Dahl, Jaideep V. Thottassery, Sima Jeha, Kelly W. Maloney, J Paul, Elly Barry, William L. Carroll, Paul S. Gaynon   +16 more
openalex   +1 more source

Data from Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy

, 2023
Yuval Shaked, Urban Emmenegger, Giulio Francia, Limor Chen, Christina R. Lee, Shan Man, Armen Paraghamian, Yaacov Ben‐David, Robert S. Kerbel   +8 more
openalex   +1 more source

Low Dose Pegylated Interferon Alpha as a First‐Line Treatment for Necrobiotic Xanthogranuloma

JEADV Clinical Practice, EarlyView.
ABSTRACT Necrobiotic xanthogranuloma (NXG) is a rare, progressive granulomatous disorder frequently associated with monoclonal gammopathy, particularly monoclonal gammopathy of undetermined significance (MGUS). It typically presents with indurated to ulcerative yellowish plaques or nodules, often with ocular involvement.
Ishana Dixit, Charmaine Vanessa S. Chamberlin, Pablo Fernandez‐Peñas   +2 more
wiley   +1 more source

Efficacy of melflufen in multiple myeloma with mutated or deleted TP53. [PDF]

Exp Hematol Oncol
Acs K, Miettinen JJ, Sergeev P, Heckel T, Diao Y, Witt-Mulder K, Thureson M, Bischler T, Huppunen ME, Suvela M, Obermüller J, Munawar U, Slipicevic A, Bargou RC, Lehmann F, Gelius SS, Norin S, Schjesvold F, Sonneveld P, Stühmer T, Heckman CA.   +20 more
europepmc   +1 more source

Low serum albumin levels and the nongerminal center B-cell subtype according to the Hans algorithm as strong prognostic factors in ≥ 80-year-old patients with large B-cell lymphoma treated with rituximab-containing chemotherapy. [PDF]

Ann Hematol
Kawashima I, Nakadate A, Hyuga H, Matsuura M, Sakamoto Y, Suzuki J, Kumagai T, Suzuki M, Yamanda-Koshiishi M, Yamamoto T, Nakajima K, Oishi N, Kondo T, Kirito K.   +13 more
europepmc   +1 more source

Pyoderma gangrenosum associated with granulomatosis with polyangiitis: a case report. [PDF]

J Med Case Rep
Ben Brahim M, Abdellatif S, Ben Mabrouk A, Jomaa O, Chebil A, Hasnaoui M, Arfa S, Berriche O.   +7 more
europepmc   +1 more source